Metropolitan Life Insurance Company (MetLife)’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-39,519
| Closed | -$443K | – | 2560 |
|
|
2017
Q3 | $443K | Hold |
39,519
| – | – | ﹤0.01% | 1771 |
|
|
2017
Q2 | $435K | Hold |
39,519
| – | – | ﹤0.01% | 1804 |
|
|
2017
Q1 | $387K | Hold |
39,519
| – | – | ﹤0.01% | 1838 |
|
|
2016
Q4 | $427K | Buy |
39,519
+2,389
| +6% | +$23.9K | ﹤0.01% | 1849 |
|
|
2016
Q3 | $381K | Sell |
37,130
-2,740
| -7% | -$29.8K | ﹤0.01% | 1879 |
|
|
2016
Q2 | $521K | Sell |
39,870
-1,020
| -2% | -$13.4K | ﹤0.01% | 1662 |
|
|
2016
Q1 | $450K | Buy |
40,890
+1,518
| +4% | +$13.5K | ﹤0.01% | 1644 |
|
|
2015
Q4 | $362K | Hold |
39,372
| – | – | ﹤0.01% | 1851 |
|
|
2015
Q3 | $273K | Sell |
39,372
-964
| -2% | -$8.26K | ﹤0.01% | 2043 |
|
|
2015
Q2 | $396K | Sell |
40,336
-3,210
| -7% | -$29.2K | ﹤0.01% | 1913 |
|
|
2015
Q1 | $386K | Sell |
43,546
-403
| -0.9% | -$3.21K | ﹤0.01% | 1704 |
|
|
2014
Q4 | $385K | Hold |
43,949
| – | – | ﹤0.01% | 1947 |
|
|
2014
Q3 | $303K | Buy |
43,949
+22,014
| +100% | +$132K | ﹤0.01% | 2070 |
|
|
2014
Q2 | $115K | Sell |
21,935
-26,554
| -55% | -$129K | ﹤0.01% | 2673 |
|
|
2014
Q1 | $221K | Hold |
48,489
| – | – | ﹤0.01% | 2405 |
|
|
2013
Q4 | $244K | Hold |
48,489
| – | – | ﹤0.01% | 2327 |
|
|
2013
Q3 | $246K | Buy |
48,489
+1,272
| +3% | +$7.08K | ﹤0.01% | 2267 |
|
|
2013
Q2 | $234K | Buy |
+47,217
| New | +$225K | ﹤0.01% | 2239 |
|
Metropolitan Life Insurance Company (MetLife)'s SCLN Position: Q4 2017 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q4 2017, closing a stake of 39,519 shares — an estimated $443K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in SCLN in Q2 2013 and held it in 18 quarters. The position peaked at $521K in Q2 2016. 0 funds tracked by Wall St. Rank hold SCLN as of Q4 2017.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Sciclone Pharmaceuticals Inc position as of Q4 2017 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 39,519 Sciclone Pharmaceuticals Inc shares in Q4 2017, an estimated $443K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Sciclone Pharmaceuticals Inc in Q2 2013 and held it in 18 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Sciclone Pharmaceuticals Inc position peaked at $521K in Q2 2016.
- 0 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q4 2017.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2017, filed 15 Feb 2018.